1. Home
  2. INDI vs VALN Comparison

INDI vs VALN Comparison

Compare INDI & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$4.41

Market Cap

688.9M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$8.88

Market Cap

820.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
VALN
Founded
2007
2012
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
688.9M
820.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
INDI
VALN
Price
$4.41
$8.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$6.25
$15.75
AVG Volume (30 Days)
3.4M
19.2K
Earning Date
11-06-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$217,396,000.00
$211,089,992.00
Revenue This Year
$1.91
$5.08
Revenue Next Year
$30.15
$12.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.48
52 Week Low
$1.53
$3.62
52 Week High
$6.05
$12.25

Technical Indicators

Market Signals
Indicator
INDI
VALN
Relative Strength Index (RSI) 55.32 43.43
Support Level $3.44 $8.62
Resistance Level $4.76 $9.18
Average True Range (ATR) 0.27 0.29
MACD 0.14 0.01
Stochastic Oscillator 78.26 14.73

Price Performance

Historical Comparison
INDI
VALN

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: